SUMMARY Neutrophif function studies have been carried out in a series of 44 patients with primary myelodysplastic syndromes (MDS). In vitro tests of phagocytosis and killing of Candida guilliermondii and Staphylococcus aureus identified 13 patients with abnormal neutrophil function at presentation and a further 10 who developed abnormalities during the course of their disease. The incidence of defective function in the five disease categories in this series was: refractory cytopenia (RC) 8/17; refractory cytopenia with sideroblastic change (RC + SC) 5/8; acquired idiopathic sideroblastic anaemia (AISA) 2/4; refractory anaemia with excess blasts (RAEB) 7/11; chronic myelomonocytic leukaemia (CMML) 1/4. Eleven of 23 patients with defective neutrophil function experienced severe infective complications; in only three of these patients were neutrophil counts < 1 x 109/l and susceptibility to infection was considered to reflect, at least partially, qualitative neutrophil abnormalities. There was no correlation between absolute neutrophil count and defective function. Abnormal overall neutrophil microbicidal activity was equally associated with impaired and normal phagocytosis. Some patients with intracellular killing defects had reduced myeloperoxidase (MPO) activities and one had reduced hexose monophosphate shunt (HMPS) activity. In two patients, whose neutrophils showed markedly impaired candidacidal activity, levamisole corrected function when added in vitro at 10-7M and also when administered in therapeutic dosage. It is suggested that deranged function, probably reflecting abnormalities in maturation of the granulocyte series, occurs across the myelodysplastic spectrum and that several microbicidal mechanisms may be defective.
Neutrophil abnormalities are recognised as one feature of "preleukaemia." Neutropenia is common and hypogranularity and Pelger-Huet-like changes are frequently observed in blood films. ' 2 An increased susceptibility to infection which is not necessarily simply a reflection of neutropenia (if present) has been noted and neutrophil dysfunction suggested as an underlying cause.34 The data substantiating this are sparse but clear-cut bactericidal and candidacidal defects have been described, notably by Breton-Gorius et al. 4' Although there are other reports of clinically significant microbicidal defects in such patients,5-8 the numbers investigated have been small.
It is now apparent that there is a spectrum of related disease states which include "preleukaemia"' but which show considerable variation in the risk of transformation to a blastic phase.9 10 The range of Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders without discernible abnormalities in granulopoiesis or thrombopoiesis (as assessed by light microscopy). The present study, of 44 patients, was initiated because of the need for an investigation of the neutrophil function of a larger series of patients across the MDS spectrum of disorders; the principal aims were to assess the incidence of defective phagocytosis and intracellular killing of bacteria and fungi and to compare the findings in the definable categories. The further investigation and treatment of some of these patients also provided data relating to possible underlying abnormal microbicidal mechanisms.
Material and methods
Forty-four patients with myelodysplastic syndromes (MDS) were investigated. Their ages ranged from 40 to 87 (mean 65) yr. The following categories were distinguished on the basis of peripheral blood and bone marrow films examined by light microscopy: refractory cytopenia (RC) (17 patients); refractory cytopenia with sideroblastic change (RC + SC) (8 patients); acquired idiopathic sideroblastic anaemia (AISA) (4 patients); refractory anaemia with excess blasts (RAEB) (11 patients); chronic myelomonocytic leukaemia (CMML) (4 patients) (Table 1) . Neutrophil function studies were in many cases carried out longitudinally during the course of the disease as well as at the time of diagnosis; the period of follow-up, which in some cases was as long as two years, averaged three months. Neutrophil function tests were not carried out during episodes of clinically or microbiologically diagnosed infection because of the possibility of misleading results. Neutrophils from patients were always tested in parallel with neutrophils from normal control subjects (chiefly laboratory staff volunteers). Control data obtained over a period of three years was also used in the statistical method for determining the indices of function. A 5'chromium release candidacidal assay measured neutrophil candidacidal activity by the release of 51chromium from labelled Cguilliermondii. 14 15 Triplicate assays were set up comprising 5 x 105 neutrophils and 1-5 x 106 51Cr C guilliermondii in 0-5 ml HBSS-AB. After 60 min incubation 0-1 ml sodium deoxycholate (24 mg/ml) and 0.2 ml DNase (0.1 mg/ml) were added for 15 min and the tubes then centrifuged for 10 min at 2000 g: 0.2 ml of each supernatant was removed for gamma counting. The results were expressed by the following formula:
% release = X S x 100 T-S where X is the radioactivity released in the presence of neutrophils, S is the spontaneous release after incubation in medium, T is the total radioactivity in 0-2 ml of assay mixture.
Phagocytosis of candida
The technique of Yamamura et al'6 was adapted for use with C guilliermondii whereby the uptake of 3H-uridine by non-ingested organisms was used as a measure of phagocytosis. '7 The results from each assay, for all control neutrophils tested over a period of three years, were accumulated and found to fit a normal distribution pattern. '7 The numbers of controls for the individual Reduced microbicidal activity was associated with impaired phagocytosis in seven patients but normal phagocytosis in eight patients. In a further six patients showing impaired microbicidal activity, phagocytosis was not tested. In two patients, although neutrophils showed reduced phagocytic ability, the overall microbicidal activity was within the normal range.
The incidence of abnormal tests in the 23 patients showing impaired neutrophil function at some time during the study is shown in Table 2 , together with an indication as to the occurrence of infective problems: 11 of these patients had one or more severe infections. All three patients who died of infection had RAEB. This may be contrasted with the absence of severe infective problems in the 21 patients who showed no abnormalities of neutrophil function.
RELATIONS BETWEEN NEUTROPHIL FUNCTION, ABSOLUTE COUNT AND INCIDENCE OF INFECTIONS
The possibility that neutrophil function as tested in vitro might show a correlation with the absolute neutrophil count (PMN) was investigated for LCI, LRI 
MODULATION OF FUNCTION BY LEVAMISOLE
In the two patients investigated in detail for the effects of levamisole, the addition of 10-'M levamisole to the assay system corrected defective candidacidal activity but had no effect on control neutrophil function or on candida viability per se (Fig. 2) . This was a reproducible phenomenon. In vitro neutrophil function was also monitored before and during the oral administration of levamisole in "therapeutic" dosage. The changes in candidacidal activity for patient MCh, who had RAEB, are shown in Fig. 3 In one of five cases (GC, who had RC) tested for HMPS activity, reduced candida killing ability was associated with abnormally low post-phagocytic HMPS activity (LRI = -1.18; log increase in cpm: Martin In one case impaired microbicidal ability could not be explained by abnormalities in either MPO or HMPS activity, which were both normal.
Thirteen of the 21 patients with normal neutrophil function were tested for their MPO levels. In 12 of these 13 cases, neutrophil MPO levels were normal; one patient (WS), investigated on six occasions, was unusual in having normal tests of function but consistently low MPO levels (mean = 04 enzyme units/106 PMN). He had AISA but has since developed RC + SC.
Discussion
The results of the present investigations suggest that defects in neutrophil function, as tested in vitro, are common in patients with the myelodysplastic syndromes: 23 of 44 patients had one or more neutrophil functional abnormalities when tested in vitro. In seven patients there was reduced microbicidal activity associated with impaired phagocytosis; in eight patients phagocytosis was normal but intracellular killing impaired; in six patients the overall microbicidal activity was impaired but phagocytosis was not measured; and in two patients only phagocytosis was impaired.
The broadly similar incidence of abnormalities in the main disease categories-RC, RC + SC and RAEB would suggest that such qualitative defects reflect the dysgranulopoiesis which may occur in all these disorders, whether relatively "benign" or more obviously preleukaemic. The variability of the abnormalities is consistent with data on the expression of Fc-IgG and C3b receptors by maturing granulocytes, presumably reflecting the heterogeneity of the MDS and variation in the degree of dysgranulopoiesis. 25 The demonstration of the platelet dysfunction in these patients26 is consistent with the concept of an underlying stem cell disorder which may be variably expressed in one or more cell lines. The occurrence of abnormalities in AISA supports its inclusion in the MDS "spectrum", though further studies, especially longitudinal, of patients in this category are required.
Increased susceptibility to infection is recognised as a feature of MDS and, although this may chiefly reflect neutropenia, it has been pointed out that frequent and severe infections occur in patients with normal neutrophil counts.34 This fact, and the often strikingly abnormal morphology in blood and marrow films, have encouraged the view that clinically significant qualitative abnormalities occur in these disorders although relatively few patients have been investigated. In the previous largest series of 17 patients, a tendency towards reduced neutrophil phagocytic and bactericidal activity was reported but the difference between patients and simultaneously tested controls was not striking in any of these cases, consistent with a low incidence of infective problems in this particular group.7 In the present study, patients who at some stage had severe infections also tended to show functional defects in the in vitro tests and this could not be attributed to infections as the coincidence of active infection and critical testing was avoided. Approximately half of those patients who had abnormal tests experienced such infective problems. This susceptibility to infection was probably not simply a reflection of neutropenia: low neutrophil counts were observed in patients with and without a history of recurrent infections.
The possibility that qualitative and quantitative abnormalities were directly related required consideration, though previous studies argued against this: no correlation between indices of function and absolute neutrophil count was found. In view of the complexity of the mechanisms involved it is hardly surprising that there was no correlation between morphological appearances as assessed in blood films and tests of function. Hypogranularity and in particular, myeloperoxidase (MPO) deficiency, has been put forward as the explanation for impaired microbicidal activity.34527 Of the eight patients showing defective neutrophil intracellular killing ability, six were investigated for neutrophil MPO content: four showed reduced levels at some time and coincidence with microbicidal dysfunction was observed. The findings in one other patient who had consistently normal neutrophil function and yet abnormally low MPO levels may appear to add confusion but support the concept that "back-up" killing mechanisms exist, whereby non-enzymatic microbicidal activity is increased to "compensate" for MPO deficiency. In this study the MPO estimations represented the net level of enzyme and did not distinguish subpopulations of neutrophils with differing MPO content as described by Breton-Gorius et al,427 who suggested that in addition to an absolute deficiency of MPO in some neutrophils, the azurophil granules could show considerable variation in MPO content and that degranulation could also be defective. Whatever the mechanisms, a lack Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders of MPO in the phagocytic vacuole may result in impaired microbicidal activity and variably impaired maturation in the granulocyte series28 would explain abnormalities seen in the MDS. In tests of function which assess the overall competence of neutrophil populations it is the net effect of any deficiency which will determine the result.
Although MPO deficiency may be one likely cause of dysfunction it is clear that other mechanisms concerned with phagocytosis and intracellular killing of microorganisms may also be deranged. Of five patients showing normal phagocytosis but defective intracellular killing ability who were investigated for HMPS activity, one had reduced activity. The metabolic burst, as measured by HMPS activity is triggered by perturbation of the plasma membrane during phagocytosis. It is typically defective in chronic granulomatous disease (CGD)29 associated with NADPH oxidase deficiency30 or absence of membrane-associated cytochrome b.3' Our results imply a similar defect in our patient, as yet undefined.
We have demonstrated that levamisole, whether simply added to the test system in vitro or administered to patients in therapeutic dosage, can enhance previously depressed neutrophil function. Although the mechanism of action of levamisole is still obscure,13 one possibility is that it may have an effect on cyclic nucleotide levels and therefore on degranulation. 32 The possible link between cyclic nucleotide levels and degranulation in patients with these disorders requires further study.
The microbicidal defects found in our investigation were, in some instances, severe and approached the degree of change seen in chronic granulomatous disease. In other cases the indices of function were either mildly abnormal or at the lower end of the normal range. While it is difficult to assess the clinical significance of in vitro tests, particularly in the "grey area" of mild abnormality, there was a striking correlation between the findings of clear-cut neutrophil defects and the liability to severe infections. It has been suggested that even mild functional defects may assume importance at low neutrophil counts.33 Furthermore, micro-organisms which are not killed following ingestion may be readily disseminated.34 Impaired neutrophil function is probably an important factor underlying lifethreatening infections in this category of patient. It would seem worthwhile to monitor neutrophil function in the MDS in order to identify patients who may be particularly at risk. Although improved methodology makes the simultaneous investigation of several aspects of function feasible it can be difficult, and is sometimes impossible, to carry out a complete range of tests in patients who are also severely neutropenic; close monitoring of such patients will require further technical advances.
